Read + Share
Amedeo Smart
Independent Medical Education
Geng X, Zhu Y, Gao Y, Chong H, et al. Development of lipopeptide-based HIV-1/2 fusion inhibitors targeting the gp41 pocket site with a new design strategy. Antiviral Res 2024 Nov 23:106042. doi: 10.1016/j.antiviral.2024.106042.PMID: 39586543
Email
LinkedIn
Privacy Policy